These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 460262)

  • 1. Fatty acid supplementation in cystic fibrosis.
    Berg U; Kallner A; Kusoffsky E; Strandvik B
    Monogr Paediatr; 1979; 10():1-4. PubMed ID: 460262
    [No Abstract]   [Full Text] [Related]  

  • 2. Cimetidine in cystic fibrosis. Effect on steatorrhoea and serum fatty acids.
    Suarez Cortina L; Arranz Pena I; Camarero Salces C; Escobar Castro H
    Acta Paediatr Belg; 1980; 33(1):23-5. PubMed ID: 7405584
    [No Abstract]   [Full Text] [Related]  

  • 3. Taurine improves the absorption of a fat meal in patients with cystic fibrosis.
    Belli DC; Levy E; Darling P; Leroy C; Lepage G; Giguère R; Roy CC
    Pediatrics; 1987 Oct; 80(4):517-23. PubMed ID: 3658570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatty acid alterations and n-3 fatty acid supplementation in cystic fibrosis.
    Al-Turkmani MR; Freedman SD; Laposata M
    Prostaglandins Leukot Essent Fatty Acids; 2007; 77(5-6):309-18. PubMed ID: 18036797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fatty acids composition of serum lipid fractions in children with cystic fibrosis of the pancreas before and after treatment with pancreatin].
    Annibaldi L; Antonelli M; Ballati G; Giardini O; Cardi E
    Riv Clin Pediatr; 1968; 81(5):962-4. PubMed ID: 5740224
    [No Abstract]   [Full Text] [Related]  

  • 6. Dietary essential fatty acids in cystic fibrosis.
    Rosenlund ML; Selekman JA; Kim HK; Kritchevsky D
    Pediatrics; 1977 Mar; 59(3):428-32. PubMed ID: 840562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipids in cystic fibrosis.
    Rosenlund ML; Walsh EP; Scott DA; Kritchevsky D
    Curr Concepts Nutr; 1979; 8():219-27. PubMed ID: 393469
    [No Abstract]   [Full Text] [Related]  

  • 8. Rational use of intravenous fat emulsions.
    Pelham LD
    Am J Hosp Pharm; 1981 Feb; 38(2):198-208. PubMed ID: 6782871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of taurine supplements on growth, fat absorption and bile acid on cystic fibrosis.
    Carrasco S; Codoceo R; Prieto G; Lama R; Polanco I
    Acta Univ Carol Med (Praha); 1990; 36(1-4):152-6. PubMed ID: 2130680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatty acids in blood and intestine following docosahexaenoic acid supplementation in adults with cystic fibrosis.
    Jumpsen JA; Brown NE; Thomson AB; Paul Man SF; Goh YK; Ma D; Clandinin MT
    J Cyst Fibros; 2006 May; 5(2):77-84. PubMed ID: 16507353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral supplementation with a high-fat, high-energy product improves nutritional status and alters serum lipids in patients with cystic fibrosis.
    Rettammel AL; Marcus MS; Farrell PM; Sondel SA; Koscik RE; Mischler EH
    J Am Diet Assoc; 1995 Apr; 95(4):454-9. PubMed ID: 7699188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatty acids platelets and oxidative markers following intravenous n-3 fatty acids administration in cystic fibrosis: An open pilot observational study.
    Durieu I; Vericel E; Guichardant D; Roth H; Steghens JP; Drai J; Josserand RN; Fontaine E; Lagarde M; Bellon G
    J Cyst Fibros; 2007 Sep; 6(5):320-6. PubMed ID: 17257908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overview of monitoring and supplementation of omega 3 fatty acids in cystic fibrosis.
    Coste TC; Armand M; Lebacq J; Lebecque P; Wallemacq P; Leal T
    Clin Biochem; 2007 May; 40(8):511-20. PubMed ID: 17316592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyunsaturated fatty acids in cystic fibrosis are related to nutrition and clinical expression of the disease.
    Walkowiak J; Lisowska A; Blaszczynski M; Przyslawski J; Walczak M
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):488-9; author reply 489. PubMed ID: 18030219
    [No Abstract]   [Full Text] [Related]  

  • 15. A therapeutic trial of fatty acid supplementation in cystic fibrosis.
    Elliott RB
    Pediatrics; 1976 Apr; 57(4):474-9. PubMed ID: 1264542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correction of fatty acid metabolism in stomach surgery patients by the infusion of a fatty emulsion].
    Dzis' RP
    Vestn Khir Im I I Grek; 1986 Feb; 136(2):123-6. PubMed ID: 3705332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parenteral lipid emulsions in paediatrics.
    Krohn K; Koletzko B
    Curr Opin Clin Nutr Metab Care; 2006 May; 9(3):319-23. PubMed ID: 16607135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of lyophilized total pancreas on plasma lipids and on fat absorption in cystic fibrosis.
    Malmendier CL; Van Den Bergen CJ; Baran D
    Helv Paediatr Acta; 1977 Jul; 32(2):115-28. PubMed ID: 617969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term use of medium chain triglycerides in cystic fibrosis (author's transl)].
    Widhalm K; Götz M
    Wien Klin Wochenschr; 1976 Sep; 88(17):557-61. PubMed ID: 997539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Intralipid 10% and Intralipid 20% as a source of energy and essential fatty acids--a multicenter study.
    Meng HC; Zayan M; Kahn S; Hirsch JD; Wolfe BM; Barbosa-Saldivar JL; Bradley DL
    Acta Chir Scand Suppl; 1983; 517():179-203. PubMed ID: 6428103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.